KAPRUKA

#CRXT New Targets @$12-14.3-20 UPTO 280%

Long
NASDAQ:CRXT   None
Sector: Health Technology
Industry: Pharmaceuticals: Major


Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company's first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Target : USD 12-14.3-20
Resistance 2 : USD 10.15
Resistance 1 : USD 06.78

Support 1 : USD 3.37

**Disclaimer - This is not a financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
Do not view this idea as a recommendation for trading or investing. Risk Only What You Can Afford. Always Use a Stop Loss. Past performance is not necessarily a guide to future performance.

I would appreciate your feedback on my analysis.

Cheers
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.